📣 VC round data is live. Check it out!

SonoScape Valuation Multiples

Discover revenue and EBITDA valuation multiples for SonoScape and similar public comparables like Sinocare, Tandem Diabetes Care, Enovis, Daan Gene and more.

SonoScape Overview

About SonoScape

Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.


Founded

2002

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $360M
EBITDA: $45M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SonoScape Financials

SonoScape reported last 12-month revenue of $360M and EBITDA of $45M.

In the same LTM period, SonoScape generated $225M in gross profit, $45M in EBITDA, and $38M in net income.

Revenue (LTM)


SonoScape P&L

In the most recent fiscal year, SonoScape reported revenue of $341M and EBITDA of $40M.

SonoScape is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 12%, and net margin of 9%.

See analyst estimates for SonoScape
LTMLast FY202320242025202620272028
Revenue$360M$341M$313M$298M$341M
Gross Profit$225M$212M$218M$190M$212M
Gross Margin62%62%69%64%62%
EBITDA$45M$40M$81M$31M$40M
EBITDA Margin13%12%26%11%12%
EBIT Margin10%8%24%10%8%
Net Profit$38M$29M$67M$21M$29M
Net Margin11%9%21%7%9%

Financial data powered by Morningstar, Inc.

SonoScape Stock Performance

SonoScape has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


SonoScape's stock price is $3.02.

SonoScape share price increased by 0.4% in the last 30 days, and decreased by 30.0% in the last year.

SonoScape has an EPS (earnings per share) of $0.07.

See more trading valuation data for SonoScape
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.7%0.4%-19.4%-30.0%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SonoScape Valuation Multiples

SonoScape trades at 3.1x EV/Revenue multiple, and 24.6x EV/EBITDA.

See NTM and 2027E valuation multiples for SonoScape

EV / Revenue (LTM)


SonoScape Financial Valuation Multiples

As of June 3, 2026, SonoScape has market cap of $1B and EV of $1B.

SonoScape has a P/E ratio of 33.8x.

LTMLast FY202320242025202620272028
EV/Revenue3.1x3.3x3.6x3.7x3.3x
EV/EBITDA24.6x27.8x13.8x35.4x27.8x
EV/EBIT32.2x40.9x14.8x38.0x40.9x
EV/Gross Profit5.0x5.3x5.1x5.9x5.3x
P/E33.8x44.0x19.1x61.0x44.0x
EV/FCF(88.2x)(39.6x)24.1x75.5x(39.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SonoScape Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SonoScape Margins & Growth Rates

SonoScape grew revenue by 15% and EBITDA by 55% in the last fiscal year.

In the most recent fiscal year, SonoScape reported gross margin of 62%, EBITDA margin of 12%, and net margin of 9%.

See estimated margins and future growth rates for SonoScape

SonoScape Margins

Last FY202420252026202720282029
Gross Margin62%64%62%63%
EBITDA Margin12%11%12%16%
EBIT Margin8%10%8%13%
Net Margin9%7%9%13%
FCF Margin(8%)5%(8%)13%

SonoScape Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth15%(5%)15%15%
Gross Profit Growth16%(13%)11%16%
EBITDA Growth55%(61%)27%55%
EBIT Growth80%(61%)(7%)80%
Net Profit Growth73%(69%)39%73%
FCF Growth(276%)(68%)(291%)(276%)

Data powered by FactSet, Inc. and Morningstar, Inc.

SonoScape Operational KPIs

SonoScape's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SonoScape's Rule of X is 52% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for SonoScape
LTMLast FY202320242025202620272028
Rule of 4028%30%---
Bessemer Rule of X50%52%---
S&M Expenses to Revenue28%29%10%11%11%
G&A Expenses to Revenue6%6%1%1%1%
R&D Expenses to Revenue21%21%18%23%21%
Opex to Revenue-54%45%54%54%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SonoScape Competitors

SonoScape competitors include Sinocare, Tandem Diabetes Care, Enovis, Daan Gene, AtriCure, AdaptHealth, NeoGenomics, Wandong Medical, Integra Lifesciences and VCANBIO.

Most SonoScape public comparables operate across Medical Devices, Medical Imaging & Diagnostics, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Sinocare1.9x1.8x22.4x17.2x
Tandem Diabetes Care1.4x1.4x(31.2x)(430.9x)
Enovis1.2x1.2x6.6x6.4x
Daan Gene10.4x-(17.3x)-
AtriCure2.3x2.2x20.0x17.7x
AdaptHealth1.0x1.0x5.3x5.0x
NeoGenomics2.2x2.1x36.4x32.4x
Wandong Medical4.5x4.3x(24.0x)-

This data is available for Pro users. Sign up to see all SonoScape competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SonoScape

When was SonoScape founded?SonoScape was founded in 2002.
Where is SonoScape headquartered?SonoScape is headquartered in China.
Is SonoScape publicly listed?Yes, SonoScape is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of SonoScape?SonoScape trades under 300633 ticker.
When did SonoScape go public?SonoScape went public in 2017.
Who are competitors of SonoScape?SonoScape main competitors include Sinocare, Tandem Diabetes Care, Enovis, Daan Gene, AtriCure, AdaptHealth, NeoGenomics, Wandong Medical, Integra Lifesciences, VCANBIO.
What is the current market cap of SonoScape?SonoScape's current market cap is $1B.
What is the current revenue of SonoScape?SonoScape's last 12 months revenue is $360M.
What is the current revenue growth of SonoScape?SonoScape revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of SonoScape?Current revenue multiple of SonoScape is 3.1x.
What is the current EBITDA of SonoScape?SonoScape's last 12 months EBITDA is $45M.
What is SonoScape's EBITDA margin?SonoScape's last 12 months EBITDA margin is 13%.
What is the current EV/EBITDA multiple of SonoScape?Current EBITDA multiple of SonoScape is 24.6x.
What is the current FCF of SonoScape?SonoScape's last 12 months FCF is ($13M).
What is SonoScape's FCF margin?SonoScape's last 12 months FCF margin is (4%).
What is the current EV/FCF multiple of SonoScape?Current FCF multiple of SonoScape is (88.2x).
How many companies SonoScape has acquired to date?SonoScape hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SonoScape has invested to date?SonoScape hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to SonoScape

Lists including SonoScape

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial